|
Re: Patience
|
2
|
Resverlogix Corp.
|
Jun 21, 2021 09:37AM
|
|
Re: Questions about units
|
2
|
Resverlogix Corp.
|
May 18, 2019 12:56PM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 23, 2018 10:44AM
|
|
Re: Deja Vu All Over Again
|
2
|
Resverlogix Corp.
|
Mar 10, 2022 07:00PM
|
|
Re: Article
|
2
|
Resverlogix Corp.
|
Oct 25, 2020 01:02PM
|
|
Re: I wonder...
|
2
|
Resverlogix Corp.
|
Jan 23, 2020 10:23AM
|
|
Re: ...somebody’s having fun...
|
2
|
Resverlogix Corp.
|
Feb 21, 2019 05:00PM
|
|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
2
|
Resverlogix Corp.
|
May 03, 2019 04:42PM
|
|
Company to extend the filing deadline
|
2
|
Resverlogix Corp.
|
Sep 11, 2020 02:27PM
|
|
Re: Apabetalone......a Calculated Risk
|
2
|
Resverlogix Corp.
|
Apr 09, 2019 08:38AM
|
|
Re: ZHCLF trading
|
2
|
Zenith Epigenetics
|
Feb 08, 2021 12:59PM
|
|
Re: Diabetes, dementia, and ABL
|
2
|
Resverlogix Corp.
|
Dec 21, 2019 08:55AM
|
|
Re: Shawn lu RSU and option cancelled
|
2
|
Resverlogix Corp.
|
Apr 05, 2020 10:28AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
2
|
Resverlogix Corp.
|
Aug 07, 2020 11:56AM
|
|
Re: Nice bump today in the share price
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 05, 2021 06:15AM
|
|
Re: Deal Closing?
|
2
|
Resverlogix Corp.
|
May 28, 2019 10:27AM
|
|
Re: Financials/MD&A -SEDAR June 30/22
|
2
|
Resverlogix Corp.
|
Aug 13, 2022 01:28PM
|
|
Re: Shareholder Value
|
2
|
Zenith Epigenetics
|
Aug 07, 2021 12:02PM
|
|
Re: ORI
|
2
|
Resverlogix Corp.
|
Oct 15, 2020 06:54PM
|
|
Re: HDL from an Alzheimer's disease perspective
|
2
|
Resverlogix Corp.
|
Jun 27, 2019 09:30AM
|
